Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.
Drug Des Devel Ther. 2024 Oct 24;18:4723-4748. doi: 10.2147/DDDT.S478388. eCollection 2024.
α-Mangostin, initially identified in 1855, is a xanthone derivative compound predominantly located in the pericarp of the mangosteen fruit ( L). This compound is known for its beneficial properties as an antioxidant and anti-inflammatory agent, still holding promise for potential benefits in other related pathologies. In the investigative process, computational studies have proven highly valuable in providing evidence and initial screening before progressing to preclinical and clinical studies. This review aims to present the pharmacological findings and mechanisms of action of α-mangostin based on computational studies. The compilation of this review is founded on the analysis of relevant articles obtained from PubMed, Scopus, and ScienceDirect databases. The study commences with an elucidation of the physicochemical characteristics, drug-likeness, pharmacokinetics, and toxicity profile of α-mangostin, which demonstrates that α-mangostin complies with the Lipinski's Rule of Five, exhibits favorable profiles of absorption, distribution, metabolism, and excretion, and presents low toxicity. Subsequent investigations have revealed that computational studies employing various software tools including ArgusLab, AutoDock, AutoDock Vina, Glide, HEX, and MOE, have been pivotal to comprehend the pharmacology of α-mangostin. Beyond its well established roles as an antioxidant and anti-inflammatory agent, α-mangostin is now recognized for its pharmacological effects in Alzheimer's disease, diabetes, cancer, chronic kidney disease, chronic periodontitis, infectious diseases, and rheumatoid arthritis. Moreover, α-mangostin is projected to have applications in pain management and as a potent mosquito larvicide. All of these findings are based on the attainment of adequate binding affinity to specific target receptors associated with each respective pathological condition. Consequently, it is anticipated that these findings will serve as a foundation for future scientific endeavours, encompassing both in vitro and in vivo studies, as well as clinical investigations, to better understand the pharmacological effects of α-mangostin.
α-倒捻子素于 1855 年首次被发现,是一种主要存在于山竹果皮中的酮衍生物化合物。该化合物具有抗氧化和抗炎特性,被认为在其他相关疾病中具有潜在的益处。在研究过程中,计算研究已被证明在进行临床前和临床研究之前提供证据和初步筛选非常有价值。本综述旨在根据计算研究介绍α-倒捻子素的药理学发现和作用机制。本综述的编写基于从 PubMed、Scopus 和 ScienceDirect 数据库中获得的相关文章的分析。本研究首先阐明了 α-倒捻子素的物理化学特性、类药性、药代动力学和毒性概况,表明 α-倒捻子素符合 Lipinski 的五规则,具有良好的吸收、分布、代谢和排泄特性,且毒性较低。随后的研究表明,使用 ArgusLab、AutoDock、AutoDock Vina、Glide、HEX 和 MOE 等各种软件工具的计算研究对于理解 α-倒捻子素的药理学至关重要。除了其作为抗氧化剂和抗炎剂的既定作用外,α-倒捻子素现在还被认为在阿尔茨海默病、糖尿病、癌症、慢性肾病、慢性牙周炎、传染病和类风湿性关节炎方面具有药理学作用。此外,α-倒捻子素有望在疼痛管理和作为有效的蚊虫杀虫剂方面得到应用。所有这些发现都是基于与每种特定病理状况相关的特定靶受体获得足够的结合亲和力。因此,预计这些发现将为未来的科学努力提供基础,包括体外和体内研究以及临床研究,以更好地理解 α-倒捻子素的药理学作用。